Insight Molecular Diagnostics Inc.
IMDX· Nasdaq
Insight Molecular Diagnostics Inc.
- Last sale
- Oct 2, 2026 · -1.29%
- Market cap
- $112.24M
- 32.72M shares
- Filings
- 688
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $4,055,000 | reported | |
| FY 2024 | 2024-12-31 | $1,881,000 | reported | |
| FY 2023 | 2023-12-31 | $1,503,000 | reported | |
| FY 2022 | 2022-12-31 | $958,000 | reported | |
| FY 2021 | 2021-12-31 | $2,198,000 revised | reported | |
| FY 2020 | 2020-12-31 | $1,216,000 | reported | |
| FY 2015 | 2015-12-31 | $0 | reported |
Insight Molecular Diagnostics Inc. · CIK 1642380 · Engraved from SEC EDGAR
